Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science

Abstract Vericiguat, a novel soluble guanylate cyclase (sGC) stimulator, is approved for the treatment of heart failure (HF) with reduced ejection fraction (HFrEF). Decreased nitric oxide (NO) availability, sGC desensitization to NO, sGC deficiency, and reduced cyclic guanosine monophosphate (cGMP)...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria E. Trujillo (Author), Surya Ayalasomayajula (Author), Robert O. Blaustein (Author), Ferdous Gheyas (Author)
Format: Book
Published: Wiley, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available